206 related articles for article (PubMed ID: 24643781)
1. Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs.
Nalin L; Selvaraju RK; Velikyan I; Berglund M; Andréasson S; Wikstrand A; Rydén A; Lubberink M; Kandeel F; Nyman G; Korsgren O; Eriksson O; Jensen-Waern M
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1800-10. PubMed ID: 24643781
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular side-effects and insulin secretion after intravenous administration of radiolabeled Exendin-4 in pigs.
Rydén A; Nyman G; Nalin L; Andreasson S; Velikyan I; Korsgren O; Eriksson O; Jensen-Waern M
Nucl Med Biol; 2016 Jul; 43(7):397-402. PubMed ID: 27179248
[TBL] [Abstract][Full Text] [Related]
6. Species differences in pancreatic binding of DO3A-VS-Cys
Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I
Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030
[TBL] [Abstract][Full Text] [Related]
7. [
Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M
Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of [
Li J; Rawson J; Chea J; Tang W; Miao L; Sui F; Li L; Poku E; Shively JE; Kandeel F
Sci Rep; 2019 Apr; 9(1):5705. PubMed ID: 30952975
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible.
Selvaraju RK; Bulenga TN; Espes D; Lubberink M; Sörensen J; Eriksson B; Estrada S; Velikyan I; Eriksson O
Am J Nucl Med Mol Imaging; 2015; 5(3):259-69. PubMed ID: 26069859
[TBL] [Abstract][Full Text] [Related]
11. Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates.
Eriksson O; Velikyan I; Haack T; Bossart M; Evers A; Laitinen I; Larsen PJ; Plettenburg O; Takano A; Halldin C; Antoni G; Johansson L; Pierrou S; Wagner M
Sci Rep; 2019 Oct; 9(1):14960. PubMed ID: 31628379
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.
Wang Y; Lim K; Normandin M; Zhao X; Cline GW; Ding YS
Nucl Med Biol; 2012 Feb; 39(2):167-76. PubMed ID: 22033026
[TBL] [Abstract][Full Text] [Related]
13. New Radiolabeled Exendin Analogues Show Reduced Renal Retention.
Joosten L; Frielink C; Jansen TJP; Lobeek D; Andreae F; Konijnenberg M; Heskamp S; Gotthardt M; Brom M
Mol Pharm; 2023 Jul; 20(7):3519-3528. PubMed ID: 37265006
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
Wu Z; Todorov I; Li L; Bading JR; Li Z; Nair I; Ishiyama K; Colcher D; Conti PE; Fraser SE; Shively JE; Kandeel F
Bioconjug Chem; 2011 Aug; 22(8):1587-94. PubMed ID: 21692471
[TBL] [Abstract][Full Text] [Related]
15. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.
Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X
J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
[TBL] [Abstract][Full Text] [Related]
17. 64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.
Mikkola K; Yim CB; Fagerholm V; Ishizu T; Elomaa VV; Rajander J; Jurttila J; Saanijoki T; Tolvanen T; Tirri M; Gourni E; Béhé M; Gotthardt M; Reubi JC; Mäcke H; Roivainen A; Solin O; Nuutila P
Mol Imaging Biol; 2014 Apr; 16(2):255-63. PubMed ID: 24101374
[TBL] [Abstract][Full Text] [Related]
18. Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes.
Khera E; Zhang L; Roberts S; Nessler I; Sandoval D; Reiner T; Thurber GM
J Nucl Med; 2019 Nov; 60(11):1635-1641. PubMed ID: 31076502
[TBL] [Abstract][Full Text] [Related]
19. Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.
Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Yabe D; Inagaki N
J Diabetes Investig; 2020 Nov; 11(6):1448-1456. PubMed ID: 32323451
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
